Cargando…

The Impact of Tofacitinib on Quality of Life in Patients with Moderate-to-Severe Psoriasis- An Observational Study

BACKGROUND: Global phase III trials have established the effectiveness and the safety profile of 5 and 10 mg twice-daily regimens of Tofacitinib for the management of psoriasis. AIMS AND OBJECTIVES: This study was aimed at assessing the improvement in quality of life in patients suffering from moder...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohta, Alpana, Nyati, Asha, Ghiya, Bhikam Chand, Mehta, Rajesh Dutt, Jain, Suresh Kumar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389145/ https://www.ncbi.nlm.nih.gov/pubmed/37529464 http://dx.doi.org/10.4103/ijd.ijd_697_22

Ejemplares similares

Histopathological Spectrum of Cutaneous Reactions following COVID-19 Vaccine - An Observational Study
por: Mohta, Alpana, et al.
Publicado: (2023)

Multisystem Inflammatory Syndrome in Children Related to COVID-19 With Urticarial Vasculitis — A Double Whammy!
por: Mohta, Alpana, et al.
Publicado: (2021)

The Role of Erbium: Yag Laser in the Management of Zoon's Balanitis - A Case Report with Mini Review
por: Mohta, Alpana, et al.
Publicado: (2022)

A Case Series of Mucocutaneous Mucormycosis and its Risk Factors among SARS-CoV-2 Patients
por: Arora, Aakanksha, et al.
Publicado: (2022)

An Intention-to-Treat-Analysis of the Efficacy of Immunotherapy Using Mycobacterium W Vaccine and Purified Protein Derivative of Tuberculin for Warts With Assessment of Improvement in Quality of Life
por: Mohta, Alpana, et al.
Publicado: (2022)

Vaccine-Related Eruptions of Papules and Plaques Following COVID-19 Vaccination – A Case Series
por: Mohta, Alpana, et al.
Publicado: (2022)

Assessing the Association between Psoriasis and Cardiovascular Ischemia: An Investigation of Vascular Endothelial Growth Factor, Cutaneous Angiogenesis, and Arterial Stiffness
por: Mohta, Alpana, et al.
Publicado: (2023)

An Observational Study of Mucocutaneous Manifestations among SARS-CoV-2 Patients from Three COVID-19 Dedicated Tertiary Care Centers
por: Mohta, Alpana, et al.
Publicado: (2021)

Correlation of Vitamin D3 Levels with Disease Severity in Psoriasis Patients – A Case-Control Study
por: Mohta, Alpana, et al.
Publicado: (2022)

A Randomized Control Trial of 20% Glycolic Acid Versus 30% Salicylic Acid in the Management of Molluscum Contagiosum
por: Nai, Radhe S, et al.
Publicado: (2022)

Onset of DRESS Following COVID-19 Vaccination: Causality or Coexistence?
por: Mohta, Alpana, et al.
Publicado: (2022)

Estimating the Impact of Extragenital Warts versus Genital Warts on Quality of Life in Immunocompetent Indian Adult Patients: A Comparative Cross-Sectional Study
por: Mohta, Alpana, et al.
Publicado: (2021)

Evaluation of Impact of Tinea Capitis on Quality of Life in Pediatric Patients Using Children's Dermatology Life Quality Index and Its Correlation with Disease Duration
por: Mohta, Alpana, et al.
Publicado: (2020)

Successful Treatment of Recurrent Oral and Genital Ulcers in Behcet's Disease with Rituximab
por: Mohta, Alpana, et al.
Publicado: (2022)

A Case of Scalp White Piedra Caused by Trichosporon Ovoides
por: Singh, Arti, et al.
Publicado: (2019)

Oral condyloma lata: A rare case report
por: Sharma, Pritee, et al.
Publicado: (2021)

Intralesional Purified Protein Derivative of Tuberculin Versus Intralesional Mycobacterium W Vaccine in Treatment of Recalcitrant Extragenital Warts: A Randomized, Single-Blinded, Comparative Study
por: Mohta, Alpana, et al.
Publicado: (2022)

Evaluation of the Knowledge, Attitude and Practice of Patients on Immunosuppressive Drugs Towards COVID-19 Attending Dermatology Department- A Multicentric Cross-Section Study
por: Mohta, Alpana, et al.
Publicado: (2021)

Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
por: Di Lernia, V, et al.
Publicado: (2016)

Ocular Discoid Lupus Erythematosus: More Than what Meets The Eye
por: Pareek, Sumiti, et al.
Publicado: (2023)

Efficacy of Intralesional Bleomycin in Palmo-plantar and Periungual Warts
por: Soni, Prasoon, et al.
Publicado: (2011)

Recalcitrant periungual warts in a paediatric patient treated with intralesional vitamin D3
por: Mohta, Alpana, et al.
Publicado: (2020)

Benefit–risk profile of tofacitinib in patients with moderate‐to‐severe chronic plaque psoriasis: pooled analysis across six clinical trials
por: Strober, B.E., et al.
Publicado: (2018)

Population Pharmacokinetics of Tofacitinib in Patients With Moderate to Severe Ulcerative Colitis
por: Vong, Camille, et al.
Publicado: (2021)

Endocrinological Testicular Dysfunction in Patients with Lepromatous Leprosy and the Impact of Disease on Patient's Quality of Life
por: Mohta, Alpana, et al.
Publicado: (2020)

A Case of Acquired Arteriovenous Malformation of Lip: Clinical and Mucoscopic Evaluation
por: Mohta, Alpana, et al.
Publicado: (2020)

Salt-and-Pepper Dyspigmentation with Groove Sign in Erasmus Syndrome: A Double Jeopardy
por: Mohta, Alpana, et al.
Publicado: (2022)

Initial experience of tofacitinib for treating refractory moderate-to-severe ulcerative colitis
por: Nakamura, Masanao, et al.
Publicado: (2022)

Tofacitinib versus etanercept or placebo in patients with moderate to severe chronic plaque psoriasis: patient‐reported outcomes from a Phase 3 study
por: Valenzuela, F., et al.
Publicado: (2016)

Impact of moderate-to-severe psoriasis on quality of life in China: a qualitative study
por: Zhong, Hua, et al.
Publicado: (2021)

A Case of Eruptive Pseudoangiomatosis: Clinical, Histopathological, and Dermoscopic Findings
por: Kushwaha, Ramesh K., et al.
Publicado: (2020)

Tofacitinib Treatment Safety in Moderate to Severe Ulcerative Colitis: Comparison of Observational Population Cohort Data From the IBM MarketScan® Administrative Claims Database With Tofacitinib Trial Data
por: Curtis, Jeffrey R, et al.
Publicado: (2020)

Tofacitinib for the treatment of moderate to severe chronic plaque psoriasis in Japanese patients: Subgroup analyses from a randomized, placebo‐controlled phase 3 trial
por: Abe, Masatoshi, et al.
Publicado: (2017)

Therapy of moderate and severe psoriasis
por: Claes, Christa, et al.
Publicado: (2006)

Extraintestinal manifestations at baseline, and the effect of tofacitinib, in patients with moderate to severe ulcerative colitis
por: Rubin, David T., et al.
Publicado: (2021)

Cost Effectiveness of Tofacitinib for the Treatment of Moderate to Severe Active Ulcerative Colitis in Colombia
por: Gil, Fabio, et al.
Publicado: (2022)

Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis
por: Clowse, Megan E. B., et al.
Publicado: (2016)

Effect of tofacitinib withdrawal and re‐treatment on patient‐reported outcomes: results from a Phase 3 study in patients with moderate to severe chronic plaque psoriasis
por: Griffiths, C.E.M., et al.
Publicado: (2016)

Oral tofacitinib efficacy, safety and tolerability in Japanese patients with moderate to severe plaque psoriasis and psoriatic arthritis: A randomized, double‐blind, phase 3 study
por: Asahina, Akihiko, et al.
Publicado: (2016)

Treatment of moderate-to-severe plaque psoriasis with tildrakizumab in the real-life setting
por: Burlando, Martina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_upv6q2l9bn1oeis6tsncck47am